In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest data on the use of oral SERDs therapy, including how to incorporate this new class of therapy into treatment plans for patients with HR+/HER2- breast cancer. Presenters: Virginia Kaklamani, MD, DSc Professor of Medicine Ruth McLean Bowman Bowers Chair in Breast Cancer Research and Treatment A.B. Alexander Distinguished Chair in Oncology Leader Breast Oncology Program UT Health San Antonio MD Anderson Cancer Center San Antonio, Texas Aditya Bardia, MD, MPH, FASCO Professor of Medicine Geffen School of Medicine at UCLA Director, Breast Oncology Program Assistant Chief (Translational Research) Division of Medical Oncology Director of Translational Research Integration UCLA Health Jonsson Comprehensive Cancer Center Los Angeles, California Sarah Sammons, MD Assistant Professor of Medicine Dana-Farber Cancer Institute Harvard Medical School Boston, Massachusetts Link to full program: https://bit.ly/46hLGcM Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
